Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haakon B Nygaard

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthDharmendra Gurve, Andrew Peter Centen, Penelope J Slack, et al.
Neuron|September 10, 2013
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion proteinJi Won Um, Adam C Kaufman, Mikhail Kostylev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2025
Risk factor profiles and cognitive function in older adults: the Brain Health Support Program StudyCaroline S Duchaine, Manuel Montero-Odasso, Haakon B Nygaard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSylvie Belleville, Nicole D Anderson, John R Best, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A microglia-containing cerebral organoid model to study early life immune challengesAlice Buonfiglioli, Raphael Kübler, Roy Missall, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 10, 2024
Clinical value of Alzheimer's disease biomarker testingKhushbu J Patel, David Yang, John R Best, et al.
Brain, Behavior, and Immunity|November 5, 2024
A microglia-containing cerebral organoid model to study early life immune challengesAlice Buonfiglioli, Raphael Kübler, Roy Missall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthHaakon B Nygaard, Sylvie Belleville, Nicole D Anderson, et al.
Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisStefan Wendt, Ada J Lin, Sarah N Ebert, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthDharmendra Gurve, Andrew Peter Centen, Penelope J Slack, et al.
Neuron|September 10, 2013
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion proteinJi Won Um, Adam C Kaufman, Mikhail Kostylev, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2025
Risk factor profiles and cognitive function in older adults: the Brain Health Support Program StudyCaroline S Duchaine, Manuel Montero-Odasso, Haakon B Nygaard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSylvie Belleville, Nicole D Anderson, John R Best, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A microglia-containing cerebral organoid model to study early life immune challengesAlice Buonfiglioli, Raphael Kübler, Roy Missall, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 10, 2024
Clinical value of Alzheimer's disease biomarker testingKhushbu J Patel, David Yang, John R Best, et al.
Brain, Behavior, and Immunity|November 5, 2024
A microglia-containing cerebral organoid model to study early life immune challengesAlice Buonfiglioli, Raphael Kübler, Roy Missall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthHaakon B Nygaard, Sylvie Belleville, Nicole D Anderson, et al.
Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisStefan Wendt, Ada J Lin, Sarah N Ebert, et al.
Pageof 6